So you should be Graham.
I view the impairment write down as a very wise move in terms of sending a message to government as well as tax implications.
And the lost of staff will help keep our costs down (KP is going to have to work a lot harder now) although I did think that Kerry Angel did a very good job for next to no money.
The detail re funding sources should sit very well with investors.
- Forums
- ASX - By Stock
- PAX
- did you see that in the pre market?
did you see that in the pre market?, page-66
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAX (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online